FDA approves first radioligand equivalent, Curium’s copycat of Novartis’ Lutathera

Regulatory Approvals — FDA approves first radioligand equivalent, Curium’s copycat of Novartis’ Lutathera  Fierce Pharma

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 15, 2026.